Safety of intravenous iron formulations: facts and folklore.
作者信息
Auerbach Michael, Macdougall Iain C
机构信息
School of Medicine Georgetown University, Washington DC, United States of America.
Department of Nephrology, King's College Hospital, London, United Kingdom.
出版信息
Blood Transfus. 2014 Jul;12(3):296-300. doi: 10.2450/2014.0094-14.
Abstract
摘要
相似文献
1
Safety of intravenous iron formulations: facts and folklore.
Blood Transfus. 2014 Jul;12(3):296-300. doi: 10.2450/2014.0094-14.
2
I'm 75, and I've always taken Benadryl for my allergies. My doctor advised me to switch to a prescription allergy medication. Why?
Johns Hopkins Med Lett Health After 50. 2008 Oct;20(8):8.
3
Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?
Transfus Med Rev. 2007 Jan;21(1):1-12. doi: 10.1016/j.tmrv.2006.09.001.
4
A serum sickness-like reaction to a commonly used acne drug.
JAAPA. 2008 Mar;21(3):33-4. doi: 10.1097/01720610-200803000-00009.
5
Anaphylaxis after home-made quinoa dinner: hold the mustard.
BMJ Case Rep. 2015 Mar 2;2015:bcr2014208980. doi: 10.1136/bcr-2014-208980.
6
Anaphylaxis treatment: the details.
CMAJ. 2003 Nov 25;169(11):1148; author reply 1148-9.
7
Cardiovascular Collapse After Induction.
J Neurosurg Anesthesiol. 2015 Jul;27(3):267. doi: 10.1097/ANA.0000000000000132.
8
[Hypersensitivity reactions to intravenous iron: an allergist' perspective].
Rev Med Suisse. 2022 Apr 6;18(776):639-645. doi: 10.53738/REVMED.2022.18.776.639.
9
Risks for Anaphylaxis With Intravenous Iron Formulations.
Ann Intern Med. 2022 Nov;175(11):W143-W144. doi: 10.7326/L22-0283.
10
Risks for Anaphylaxis With Intravenous Iron Formulations.
Ann Intern Med. 2022 Nov;175(11):W143. doi: 10.7326/L22-0282.
引用本文的文献
1
Acute Kidney Injury Following Intravenous Iron Sucrose in a 67-Year-Old Male: A Case Report.
Cureus. 2025 Jul 21;17(7):e88440. doi: 10.7759/cureus.88440. eCollection 2025 Jul.
2
Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study.
Ther Clin Risk Manag. 2025 Jun 25;21:987-993. doi: 10.2147/TCRM.S529064. eCollection 2025.
3
Diagnosis and treatment of iron deficiency in chronic heart failure : Position statement of the heart failure working group of the Austrian Society of Cardiology.
Wien Klin Wochenschr. 2025 Mar;137(Suppl 3):143-156. doi: 10.1007/s00508-025-02521-x. Epub 2025 May 6.
4
Intravenous iron in chronic kidney disease without anaemia but iron deficiency: A scoping review.
World J Nephrol. 2025 Mar 25;14(1):101576. doi: 10.5527/wjn.v14.i1.101576.
5
How I treat iron-refractory iron deficiency anaemia-An expert opinion-based treatment guidance for children and adults.
Br J Haematol. 2025 Apr;206(4):1067-1076. doi: 10.1111/bjh.20030. Epub 2025 Feb 22.
6
Management of iron deficiency anemia during pregnancy: a midwife-led continuity of care model.
Front Nutr. 2024 May 24;11:1400174. doi: 10.3389/fnut.2024.1400174. eCollection 2024.
7
Acceptability of IV iron treatment for iron deficiency anaemia in pregnancy in Nigeria: a qualitative study with pregnant women, domestic decision-makers, and health care providers.
Reprod Health. 2024 Feb 13;21(1):22. doi: 10.1186/s12978-024-01743-y.
8
Extract from the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery - Patient Blood Management.
Blood Transfus. 2024 Mar;22(2):122-129. doi: 10.2450/BloodTransfus.708. Epub 2023 Dec 6.
9
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis.
Clin Kidney J. 2023 Jan 24;16(5):845-858. doi: 10.1093/ckj/sfac271. eCollection 2023 May.
10
Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK.
Sci Rep. 2022 Nov 7;12(1):18859. doi: 10.1038/s41598-022-23581-3.
本文引用的文献
1
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Clin J Am Soc Nephrol. 2014 Apr;9(4):705-12. doi: 10.2215/CJN.05320513. Epub 2014 Jan 23.
2
Iron toxicity: relevance for dialysis patients.
Nephrol Dial Transplant. 2014 Feb;29(2):255-9. doi: 10.1093/ndt/gft269. Epub 2013 Oct 28.
3
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia.
Anemia. 2013;2013:169107. doi: 10.1155/2013/169107. Epub 2013 Aug 29.
4
Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials.
BMJ. 2013 Aug 15;347:f4822. doi: 10.1136/bmj.f4822.
5
Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min.
Am J Hematol. 2013 Nov;88(11):944-7. doi: 10.1002/ajh.23534. Epub 2013 Sep 9.
6
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.
J Am Soc Nephrol. 2013 Jun;24(7):1151-8. doi: 10.1681/ASN.2012121164. Epub 2013 Jun 20.
7
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Transfusion. 2014 Feb;54(2):306-15. doi: 10.1111/trf.12289. Epub 2013 Jun 17.
8
Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients.
Transfusion. 2014 Feb;54(2):289-99. doi: 10.1111/trf.12195. Epub 2013 Apr 15.
9
Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis.
Am J Kidney Dis. 2013 Jun;61(6):992-1000. doi: 10.1053/j.ajkd.2012.10.027. Epub 2013 Jan 31.
10
Comparative rates of adverse events with different formulations of intravenous iron.
Am J Hematol. 2012 Nov;87(11):E123-4. doi: 10.1002/ajh.23322. Epub 2012 Sep 11.
Zotero 插件